| |
| 8:30-9:15 |
|
Patri Pal Singh (Partner 7) (WP4)
"Identification of novel drugs against tuberculosis" |
| 9:15-10:00 |
Arrival at EMBL |
Matthias Ehebauer (Partner 5) (WP4)
“Mycobacterial ACCase: A six-fold redundant set of carboxylases?” |
| 10:00-10:30 |
Coffee break |
Coffee break |
| 10:30-11:00 |
Welcome by Piet Herdewijn, Matthias Wilmanns and outline of meeting |
Yusuf Akhter (Partner 5) (WP4)
“MTB transcription factors“ |
| 11:00-11:45 |
Martin Kögler (Partner 1) (WP1,3)
“Synthesis of potential inhibitors of a novel folate-dependant thymidylate synthase in Mycobacterium tuberculosis” |
Concluding discussion
Future meetings and reporting guidelines
Project management |
| 11:45-12:30 |
Varadha Sundaramurthy (Partner 2b) (WP2,4)
“A chemical genomics approach to identify modulators of Mycobacterium phagosome maturation” |
| 12:30-13:30 |
Lunch (sandwiches) |
Lunch (sandwiches) |
| 13:30-14:15 |
Elaine Davis, Joanna Houghton (Partner 4) (WP1,2,4)
"UvrD helicases of Mtb and additional genetic contributions" |
Departure |
| 14:15-15:30 |
Arush Chhabra (Parner 6) (WP1,2)
“Developing novel inhibitors of lipid biosynthetic pathways” |
|
| 15:30-15:45 |
Coffee break |
|
| 15:45-16:30 |
Ram S. Upadhayaya (Partner 8) (WP3)
“Design and synthesis of ATP synthase and FAAL protein inhibitors” |
|
| 16:30-17:15 |
Jyoti Chattopadhyaya (Partner 3) (WP3)
“Design and synthesis of inhibitors against Mt UvrD” |
|
| 17:15-18:00 |
Arunava Dasgupta (Partner 2a) (WP2,4)
"In vitro and in vivo testing of novel compounds for their antimycobacterial activities" |
|
| 19:00 |
Dinner |
|
